Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-087566

STEMLINE THERAPEUTICS INC · STML

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kenneth Hoberman
Officer — Chief Operating Officer
Period of report
Dec 31, 2015
Accepted (ET)
Dec 31, 2015 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 31, 2015G60,000$0.00D62,119D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (Right to Buy)F2$2.21Dec 16, 2009G9,035DDec 16, 2009May 16, 2019Common Stock9,0350D
Stock Options (Right to Buy)F3$2.21Mar 22, 2010G50,965DMar 22, 2010Mar 22, 2020Common Stock63,24612,281D

Explanation of responses